Dendritic Cell Cancer Vaccine Market Insights Report 2023-2030 116 Pages Report - Benzinga
| PRRUF Stock | USD 0.20 0.00 0.00% |
Roughly 61% of Immutep's investor base is looking to short. The analysis of overall sentiment of trading Immutep Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Immutep's historical and current headlines, can help investors time the market. In addition, many technical investors use Immutep Limited stock news signals to limit their universe of possible portfolio assets.
Immutep pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immutep daily returns and investor perception about the current price of Immutep Limited as well as its diversification or hedging effects on your existing portfolios.
Immutep |
Dendritic Cell Cancer Vaccine Market Insights Report 2023-2030 116 Pages Report Benzinga
Read at news.google.com
 |
Immutep Fundamental Analysis
We analyze Immutep's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Immutep is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Immutep Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immutep pink sheet to make a market-neutral strategy. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics with similar companies.
Peers
Immutep Related Equities
| OLMA | Olema Pharmaceuticals | 7.20 | ||||
| ALXO | Alx Oncology | 6.75 | ||||
| DSGN | Design Therapeutics | 6.75 | ||||
| VRDN | Viridian Therapeutics | 6.27 | ||||
| ELEV | Elevation Oncology | 5.97 | ||||
| APLT | Applied Therapeutics | 4.84 | ||||
| ADCT | ADC Therapeutics | 4.57 | ||||
| ALVR | Allovir | 3.11 | ||||
| CRNX | Crinetics Pharmaceuticals | 2.38 | ||||
| CDTX | Cidara Therapeutics | 2.12 | ||||
| SLN | Silence Therapeutics | 1.79 | ||||
| CGEM | Cullinan Oncology | 1.18 | ||||
| GPCR | Structure Therapeutics | 0.30 | ||||
| IMMX | Immix Biopharma | 0.97 | ||||
| CTMX | CytomX Therapeutics | 1.18 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| CYTK | Cytokinetics | 2.66 | ||||
| SANA | Sana Biotechnology | 2.77 | ||||
| ENVB | Enveric Biosciences | 2.78 | ||||
| AADI | Aadi Bioscience | 4.79 | ||||
| ZNTL | Zentalis Pharmaceuticals | 6.28 |
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |